Cysteamine bitartrate
PROCYSBI (cysteamine bitartrate) is a prescription medication manufactured by Horizon Therapeutics USA, Inc., used to treat cystinosis by reducing cystine levels in the body. It comes as delayed-release capsules in 25 mg and 75 mg strengths, taken orally. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | PROCYSBI (cysteamine bitartrate) is a prescription medication manufactured by Horizon Therapeutics USA, Inc., used to treat cystinosis by reducing cystine levels in the body. It comes as delayed-release capsules in 25 mg and 75 mg strengths, taken orally. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Cysteamine bitartrate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Cysteamine bitartrate — ANDA 020392 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020392"
}
]
|
| identifier | ANDA020392 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"fda",
"medications"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Cysteamine bitartrate |
